Evidence map›Paper›PMID 26594018›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2016

Ixodes scapularis dystroglycan-like protein promotes Borrelia burgdorferi migration from the gut.

Jeroen Coumou, Sukanya Narasimhan, Jos J Trentelman, Alex Wagemakers, Joris Koetsveld, Jasmin I Ersoz, Anneke Oei, Erol Fikrig, Joppe W Hovius

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. OspA antibodies inhibit theInfection and immunity · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Interactions Between Ticks and Lyme Disease Spirochetes.Current issues in molecular biology · 2021
    Article
  6. Review
  7. Interactions between Borrelia burgdorferi and ticks.Nature reviews. Microbiology · 2020
    Review
  8. Identification of TickFrontiers in immunology · 2020
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Tick Bioactive Molecules as Novel Therapeutics: Beyond Vaccine Targets.Frontiers in cellular and infection microbiology · 2017
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Jeroen CoumouCenter for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands. j.coumou@amc.nl.ORCID http://orcid.org/0000-0002-4792-2710
Sukanya NarasimhanDepartment of Internal Medicine, Yale University School of Medicine, 06511, New Haven, CT, USA.
Jos J TrentelmanCenter for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
Alex WagemakersCenter for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
Joris KoetsveldCenter for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
Jasmin I ErsozCenter for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
Anneke OeiDepartment of Medical Microbiology, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
Erol FikrigDepartment of Internal Medicine, Yale University School of Medicine, 06511, New Haven, CT, USA.
Joppe W HoviusCenter for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
Amsterdam UMC Location University of Amsterdam · NLYale University · US

Funding

Tick Midgut Proteins Critical for Borrelia TransmissionR21AI076705 · NIAID · YALE UNIVERSITY · PI NARASIMHAN, SUKANYA · 2009 to 2010
$455k
Howard Hughes Medical InstituteNIAID NIH HHS AI076705NIAID NIH HHS R21 AI076705
6 · The paper itself

Abstract

The causative agent of Lyme borreliosis, Borrelia burgdorferi, is transmitted by Ixodes ticks. During tick feeding, B. burgdorferi migrates from the tick gut to the salivary glands from where transmission to the host occurs. B. burgdorferi-interacting tick proteins might serve as vaccine targets to thwart B. burgdorferi transmission. A previous screening for B. burgdorferi-interacting Ixodes scapularis gut proteins identified an I. scapularis putative dystroglycan protein (ISCW015049). Here, we describe the ISCW015049's protein structure and its cellular location in the tick gut in relation to B. burgdorferi migration. Secondly, in vivo B. burgdorferi-tick attachment murine models were performed to study the role of ISCW015049 during B. burgdorferi migration and transmission. In silico analysis confirmed that ISCW015049 is similar to dystroglycan and was named I. scapularis dystroglycan-like protein (ISDLP). Confocal microscopy of gut tissue showed that ISDLP is expressed on the surface of gut cells, is upregulated during tick feeding, and is expressed significantly higher in infected ticks compared to uninfected ticks. Inhibition of ISDLP by RNA interference (RNAi) resulted in lower B. burgdorferi transmission to mice. In conclusion, we have identified a dystroglycan-like protein in I. scapularis gut that can bind to B. burgdorferi and promotes B. burgdorferi migration from the tick gut. Key messages: B. burgdorferi exploits tick proteins to orchestrate its transmission to the host. B. burgdorferi is able bind to an I. scapularis dystroglycan-like protein (ISDLP). Inhibition of ISDLP in ticks results in lower B. burgdorferi transmission to mice. ISDLP is a potential target to prevent Lyme borreliosis.

Indexed as

AnimalsArthropod ProteinsBorrelia burgdorferiDystroglycansHumansImmunizationIxodesLyme DiseaseLyme Disease VaccinesMiceRabbitsRecombinant ProteinsRNAi TherapeuticsRNA, Small InterferingArthropod ProteinsDystroglycansLyme Disease VaccinesRecombinant ProteinsRNA, Small InterferingBorrelia burgdorferiIxodes scapularisLyme borreliosisPathogen transmissionTick-borne diseasesVaccination

Identifiers

PMID26594018
PMCPMC4803822
OpenAlexW2283617809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.